Investigating how pressure affects inflammation in the retina
Cellular and Molecular Mechanisms that Contribute to Pressure-Induced Retinal Inflammation and Pathology
This study is looking at how certain channels in the eye respond to pressure changes and cause inflammation, which can lead to damage in conditions like glaucoma, with the hope of finding new ways to protect your eyesight.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-10874472 on NIH RePORTER |
What this research studies
This research explores the role of mechanosensitive ion channels in driving inflammation within the retina, particularly under conditions of increased intraocular pressure, which is relevant for diseases like glaucoma. By using advanced techniques such as 2-photon microscopy and conditional mouse models, the study aims to identify how these channels contribute to neuroinflammation and neuronal injury. The researchers will investigate the interactions between retinal cells and the signaling pathways involved in this process, with the goal of finding potential therapeutic targets to alleviate damage caused by pressure-induced stress.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for or diagnosed with conditions like glaucoma or other retinal diseases associated with increased intraocular pressure.
Not a fit: Patients with retinal conditions unrelated to pressure changes or those who do not have any inflammatory responses in the retina may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that reduce inflammation and protect against vision loss in patients with pressure-related retinal diseases.
How similar studies have performed: While the specific focus on pressure-induced retinal inflammation is novel, previous research has shown success in targeting mechanosensitive ion channels in other neurodegenerative conditions.
Where this research is happening
Salt Lake City, United States
- University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Krizaj, David — University of Utah
- Study coordinator: Krizaj, David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.